跳至主要内容
临床试验/NCT03030313
NCT03030313已完成不适用

Assessment of the Temporal Changes in Nightly Respiration Rate in Combination With a Daily Symptom Reporting Application for Facilitating Early Treatment of Symptoms in COPD Patients

ResMed2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2016年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
ResMed
入组人数
50
试验地点
2
主要终点
Correlation of Respiration Rate to Indicators of Healthcare Utilization

研究概览

简要总结

Assess the feasibility of using remote respiration rate monitoring as a component of home care, how respiration rate data may be used in combination with other data to potentially improve response to symptoms, and to generate data to inform the endpoints and effect sizes of future studies.

详细描述

The research question is whether monitoring of respiration rates and variability can be helpful in management of COPD patients in conjunction with or separately from self-reported symptom scores using the COPD Co-PILOT application. Current techniques (such as patient's self-reported symptoms) have limited sensitivity and specificity with regard to predicting decompensation. Measurement of respiration parameters and the variability of the parameters may detect worsening COPD. Changes in respiration patterns may occur sufficiently far in advance of decompensation (e.g. >5 days prior to patient symptoms) such that it would allow an opportunity for earlier intervention with medical assessment and current therapeutic approaches.

The specific primary aim includes evaluation of the correlation of respiration rate parameters to indicators of healthcare utilization including drug changes, office or ER visits, hospitalization, or other clinical interventions. Secondary aims include evaluation of (i) the sensitivity and specificity of respiration rate monitoring results to predict COPD worsening requiring medical intervention, (ii) the sensitivity and specificity of respiration rate monitoring results in conjunction with COPD Co-PILOT scores or components to predict COPD worsening requiring medical intervention, and the correlation of respiration rate parameters to episode duration as defined by number of days from COPD Co-PILOT Score >1 to resolution (COPD Co-PILOT Score <1 for 7 consecutive days).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
35 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males or females age ≥35 years old
  • Documented diagnosis of moderate to very severe COPD (GOLD Level II-IV)
  • Weight ≥35 kg
  • Currently using the COPD Co-PILOT application (at least 3 months with 70% compliance)
  • Must be able to read and understand English and consent for themselves

排除标准

  • Currently using any form of non-invasive positive airway pressure ventilation
  • Diagnosis of significant heart failure (NYHA Class III or IV)
  • Cognitive impairment (determined by physician) that will make it hard to follow instructions regarding device usage
  • BMI ≥45.5
  • Residing in hospice care, Skilled Nursing Facilities or Long Term Acute Care facilities
  • Currently using a wearable drug infusion pump to deliver medication
  • Planned procedures at time of enrollment that will occur within timeframe of study and require hospitalization etc.
  • Declines to participate at any time.
  • In the opinion of the Investigator, may be non-compliant with study schedules or procedures
  • No cellular coverage at their primary residence

研究组 & 干预措施

Respiration rate monitoring

Experimental

Reassure Non-Contact Respiration Monitor

干预措施: Reassure Non-Contact Respiration Monitor (Device)

结局指标

主要结局

Correlation of Respiration Rate to Indicators of Healthcare Utilization

时间窗: 12 weeks

Indicators of healthcare utilization include change in medications for COPD, number of office or ER visits, number of hospitalizations.

次要结局

  • Sensitivity and Specificity of Respiration Rate to Predict COPD Worsening(Baseline to 12 weeks)
  • Sensitivity and Specificity of Respiration Rate in Conjunction with COPD Co-PILOT Scores to Predict COPD Worsening(12 weeks)
  • Correlation of Respiration Rate to COPD Episode Duration(12 weeks)

研究者

发起方
ResMed
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验